Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Small molecule IM boosts hair growth by changing stem cell metabolism.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Metformin helped improve the quality of life for Chinese women with PCOS, especially in physical health and symptoms like infertility, acne, and hair loss.

Moderately high prolactin levels do not cause hair loss in women.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Acne lesions start with changes in hair follicles and increase in inflammation, suggesting a cycle that could affect treatment strategies.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

3D cell-derived matrices improve tissue regeneration and disease modeling.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.